Sergio Quezada

36PUBLICATIONS
255CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Oct 07, 2026
A preinvasive regulatory T cell axis for lung cancer interception.

|Sep 15, 2026
FasL-mediated death of activated intratumoral T cells drives secondary resistance to cancer immunotherapy.

|Apr 08, 2026
Synthetic super-enhancers enable precision viral immunotherapy.

Ute Koeber, Mantas Matjusaitis, Neza Alfazema

|Feb 05, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.

Kane A Foster, Elise Rees, Louise Ainley

|Jul 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones

|Feb 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Maise Al Bakir, James L Reading, Samuel Gamble

Pageof 6

Frequent Collaborators

17 joint publications

Charles Swanton

9 joint publications

David A Moore

8 joint publications

James Reading

8 joint publications

Nicholas McGranahan